Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
|
US |
|
Regions Financial Corp
NYSE:RF
|
US |
|
C
|
Chai Watana Tannery Group PCL
SET:CWT
|
TH |
|
E
|
eMagin Corp
F:EMGA
|
US |
|
Domacom Australia Ltd
ASX:DCL
|
AU |
|
Ezra Holdings Ltd
SGX:5DN
|
SG |
|
SeaBird Exploration PLC
OSE:SBX
|
CY |
|
S
|
Santhera Pharmaceuticals Holding AG
OTC:SPHDF
|
CH |
|
FSK-Rosseti PAO
MOEX:FEES
|
RU |
|
S
|
Sherwood Corporation (Thailand) PCL
SET:SWC
|
TH |
|
M
|
Maywood Acquisition Corp
NASDAQ:MAYA
|
US |
|
S
|
Sonel SA
WSE:SON
|
PL |
|
C
|
Credit Suisse Group AG
XBER:CSX
|
CH |
|
K
|
KMW Co Ltd
KOSDAQ:032500
|
KR |
Intrinsic Value
The intrinsic value of one
CBIO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 19.21 USD,
Crescent Biopharma Inc (Pre-Reincorporation)
is
hidden
.
CBIO looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CBIO usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Crescent Biopharma Inc (Pre-Reincorporation).
Fundamental Analysis
Revenue & Expenses Breakdown
Crescent Biopharma Inc (Pre-Reincorporation)
Earnings Waterfall
Crescent Biopharma Inc (Pre-Reincorporation)
The intrinsic value of one
CBIO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 19.21 USD,
Crescent Biopharma Inc (Pre-Reincorporation)
is
hidden
.